4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-030966
Chief Development Officer acquired 684 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longpre Lara Chief Development Officer | 2023-05-10 | Grant or award | +684 | $16.92 | $11,576 | 106,843 | D: show line 1 in the form |
Loading xslF345X04/doc4.xml…